During the past decade, Peninsula Clinical Research Centre conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Peninsula Clinical Research Centre" are "Respiratory Syncytial Virus Infections" (2 trials), "Advanced Dupuytren's Disease" (1 trials), "Chronic Lung Disease and <= 24 Months of Age or" (1 trials), "Diabetes" (1 trials) and "Hypoglycemia" (1 trials). Many other conditions were trialed in "Peninsula Clinical Research Centre" in a lesser frequency.

Most popular intervention types in "Peninsula Clinical Research Centre" are "Biological" (4 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "BHT-3021" (1 trials), "BHT-Placebo" (1 trials), "Motavizumab" (1 trials), "Motavizumab, palivizumab" (1 trials) and "Palivizumab, motavizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Peninsula Clinical Research Centre" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Peninsula Clinical Research Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Peninsula Clinical Research Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Peninsula Clinical Research Centre, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".